| P2093 | author name string | Khanin MA | |
| | Kogan AE | |
| | Kardakov DV | |
| P2860 | cites work | Kinetics of coagulation factor X activation by platelet-bound factor IXa | Q28630360 |
| | An integrated study of fibrinogen during blood coagulation | Q31385320 |
| | Metabolism of antithrombin III (heparin cofactor) in man: effects of venous thrombosis and of heparin administration | Q34262883 |
| | Factor XI activation in a revised model of blood coagulation | Q34500136 |
| | Kinetics of the Factor XIa catalyzed activation of human blood coagulation Factor IX | Q34609944 |
| | Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting | Q34626895 |
| | Inactivation of factor XII active fragment in normal plasma. Predominant role of C-1-inhibitor | Q35208694 |
| | Role of human factor VIII in factor X activation | Q36982602 |
| | Fibrinogen blocks the autoactivation and thrombin-mediated activation of factor XI on dextran sulfate | Q37312644 |
| | Role of surface in surface-dependent activation of Hageman factor (blood coagulation Factor XII) | Q37584724 |
| | Comparison of the inhibition of thrombin by three plasma protease inhibitors | Q39500526 |
| | Inactivation of factor XIa by plasma protease inhibitors: predominant role of alpha 1-protease inhibitor and protective effect of high molecular weight kininogen | Q40680878 |
| | Intrinsic versus extrinsic coagulation. Kinetic considerations | Q41875932 |
| | A mathematical model of the kinetics of platelets and plasma hemostasis system interaction | Q44512140 |
| | Human coagulation factor IX. Isolation and characterization | Q44916427 |
| | High molecular weight kininogen potentiates the heparin-accelerated inhibition of plasma kallikrein by antithrombin: Role for antithrombin in the regulation of kallikrein | Q47384881 |
| | Mathematical model for the blood coagulation prothrombin time test | Q47913504 |
| | Mathematical Model of Serine Protease Inhibition in the Tissue Factor Pathway to Thrombin | Q52326492 |
| | Contact activation of the plasma coagulation cascade. I. Procoagulant surface chemistry and energy. | Q52334779 |
| | Analysis of thrombin generation in plasma. | Q52375241 |
| | An analysis of the contact phase of blood coagulation: effects of shear rate and surface are intertwined. | Q52380650 |
| | A mathematical model of the kinetics of blood coagulation. | Q52541213 |
| | Kinetics of activation and autoactivation of human factor XII. | Q52696407 |
| | Biochemistry and Physiology of Blood Coagulation | Q64357601 |
| | Initiation of blood coagulation at artificial surfaces | Q68679604 |
| | Activation of human factor V by factor Xa and thrombin | Q68747564 |
| | Effect of negatively charged activating compounds on inactivation of factor XIIa by Cl inhibitor | Q68826238 |
| | A quantitative dot immunobinding assay for coagulation factor XII in plasma | Q68826967 |
| | Role of calcium ions and the heavy chain of factor XIa in the activation of human coagulation factor IX | Q68828839 |
| | Kinetic studies on surface-mediated activation of bovine factor XII and prekallikrein. Effects of kaolin and high-Mr kininogen on the activation reactions | Q69864394 |
| | Inhibition of prothrombinase complex by plasma proteinase inhibitors | Q70232667 |
| | Radioimmunoassays for protein C and factor X. Plasma antigen levels in abnormal hemostatic states | Q70816605 |
| | Phospholipids accelerate factor IX activation by surface bound factor XIa | Q71000332 |
| | Mechanism of activation of bovine factor XI by factor XII and factor XIIa | Q72611254 |
| | Kinetics of the inhibition of factor Xa and the tissue factor-factor VIIa complex by the tissue factor pathway inhibitor in the presence and absence of heparin | Q72696729 |
| | The interrelationship of coagulation of plasma and release of peptides | Q79445334 |
| | Enzyme amplifier kinetics | Q81019968 |
| P433 | issue | 4 | |
| P304 | page(s) | 299-310 | |
| P577 | publication date | 2001-02-01 | |
| P1433 | published in | Thrombosis Research | Q15758741 |
| P1476 | title | Analysis of the activated partial thromboplastin time test using mathematical modeling | |
| P478 | volume | 101 | |